hdr isap 2019

News November 2016

PK/PD studies in CMI - the journal of ESCMID

Clinical Microbiology and Infection (CMI), the official journal of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) explicitly welcomes PK/PD articles and highlights the importance of PK/PD as a key research field to tackle antibiotic resistance. Thereby the focus of CMI spans a wide range of PK/PD aspects, from first-in-human PK of novel drug entities, target-site PK, combinations, mechanism-based PK/PD modelling to PK/PD in special patient populations.

Read more on PK/PD in CMI in an Editorial written by William Couet, the chair of ISAP's partner organization EPASG.

News August 2015

PK/PD grant opportunity
The European PK/PD study group announced a new study grant to foster collaboration across laboratories and help mentoring of young investigators who may wish to spend some time as an observer in a laboratory that can provide additional education/training that is not available locally. The grants are available up to Euro 1000 and applications are invited for 2015-16 with a deadline of October 31st. For more information please contact Jason Roberts (j.roberts2(at)uq.edu.au).

News April 2015

2nd International Conference on Polymyxins
After ICAAC/ICC 2015, we invite you to attend the 2nd International Conference on Polymyxins to learn of the latest achievements on all major aspects of the polymyxin antibiotics.

Colistin and polymyxin B are last therapeutic options for treatment of life-threatening infections caused by Gram-negative ‘superbugs', namely Pseudomonas aeruginosa, Acinetobacter baumannii, and Klebsiella pneumoniae. Since the 1st International Conference on Polymyxins in 2013 (Prato, Italy), significant progress has been made in the clinical use and pharmacology of polymyxins, in particular PK/PD/TD and nephrotoxicity, and discovery of novel polymyxin-like antibiotics.

News July 2015

ISAP members invited to comment on EMA's PK/PD guideline
The European Medicines Agency (EMA) invited several ISAP members to a workshop discussing pharmacokinetics and pharmacodynamics in the development of antibacterial medicinal products. The presentations and discussions will support the drafting of the final regulatory guideline on PK/PD of antibacterial agents, as proposed by a concept paper.

News March 2015

Best known for his contribution to the development of PK/PD principles, Dr. William A. Craig has passed away Wednesday March 11, 2015. Dr. Craig was an extraordinary man and a shining star in the fields of infectious diseases and antimicrobial therapy. His passing leaves a large void in our lives and field.
Obituary (D. Andes)